Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR6 | P50406 | 5/20 | 0.63 |
| ▸ | HTR2A | P28223 | 11/20 | 0.60 |
| ▸ | HTR2C | P28335 | 11/20 | 0.60 |
| ▸ | DRD2 | P14416 | 9/20 | 0.51 |
| ▸ | HTR1A | P08908 | 3/20 | 0.50 |
| ▸ | HTR1D | P28221 | 2/20 | 0.50 |
| ▸ | HTR7 | P34969 | 2/20 | 0.50 |
| ▸ | DRD4 | P21917 | 1/20 | 0.50 |
| ▸ | HTR1B | P28222 | 1/20 | 0.50 |
| ▸ | HTR1F | P30939 | 1/20 | 0.50 |
| ▸ | DRD3 | P35462 | 1/20 | 0.50 |
| ▸ | CHRNB2 | P17787 | 3/20 | 0.49 |
| ▸ | CHRNA7 | P36544 | 3/20 | 0.49 |
| ▸ | CHRNA4 | P43681 | 3/20 | 0.49 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | HTR2B | P41595 | 1/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.43 |
| ▸ | HTR5A | P47898 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24243771 | 0.87 | HTR2A (0.67) | HTR6HTR2AHTR2CDRD2HTR1A | |
| Valeric Acid SCHEMBL26692523 | 0.86 | DRD2 (0.50) | HTR6HTR2AHTR2CDRD2HTR1A | |
| Valproic Acid SCHEMBL26692545 | 0.84 | HTR6 (0.48) | HTR6HTR2AHTR2CDRD2HTR1A | |
| SCHEMBL26692548 | 0.83 | HTR6 (0.47) | HTR6HTR2AHTR2CDRD2HTR1A | |
| SCHEMBL26692525 | 0.82 | DRD2 (0.47) | HTR6HTR2AHTR2CDRD2HTR1A | |
| SCHEMBL24243730 | 0.82 | HTR2A (0.54) | HTR6HTR2AHTR2CDRD2HTR1A | |
| SCHEMBL26692541 | 0.80 | DRD2 (0.45) | HTR6HTR2AHTR2CDRD2HTR1A | |
| SCHEMBL26692528 | 0.80 | DRD2 (0.44) | HTR6HTR2AHTR2CDRD2HTR1A | |
| SCHEMBL30009147 | 0.80 | HTR6 (0.69) | HTR6HTR2AHTR2CDRD2HTR1A | |
| SCHEMBL24420628 | 0.80 | HTR6 (0.69) | HTR6HTR2AHTR2CDRD2HTR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260124174-A1 | COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | ATAI THERAPEUTICS INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260115167-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | ATAI THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-20260115168-A1 | COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | ATAI THERAPEUTICS INC (US) | 2026-04-30 | — | — | US | disclosed |
| US-12472163-B2 | Compositions of matter and pharmaceutical compositions | ATAI THERAPEUTICS, INC. (US) | 2025-11-18 | — | — | US | disclosed |
| US-12396982-B2 | Compositions of matter and pharmaceutical compositions | ATAI THERAPEUTICS, INC. (US) | 2025-08-26 | — | — | US | disclosed |
| US-20250235428-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | PSILERA INC. | 2025-07-24 | — | — | US | disclosed |
| US-20250064783-A1 | Compositions of Matter and Pharmaceutical Compositions | PSILERA INC. | 2025-02-27 | — | — | US | disclosed |
| US-20250041273-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | ATAI LIFE SCIENCES N.V. (DE) | 2025-02-06 | — | — | US | disclosed |
| US-12053453-B2 | Compositions of matter and pharmaceutical compositions | PSILERA INC. (US) | 2024-08-06 | — | — | US | disclosed |
| US-20230372295-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | ATAI THERAPEUTICS, INC. | 2023-11-23 | — | — | US | disclosed |
| US-11759452-B2 | Compositions of matter and pharmaceutical compositions | PSILERA INC. (US) | 2023-09-19 | — | — | US | disclosed |
| US-20220354824-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | ATAI THERAPEUTICS, INC. | 2022-11-10 | — | — | US | disclosed |
| US-11478449-B1 | Compositions of matter and pharmaceutical compositions | PSILERA INC. (US) | 2022-10-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (13 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260115168-A1 | COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | PNMT, HTR5A, TPH2 | HTR6 11/4885HTR2A 7/4885HTR2C 5/4885 |
| US-20250235428-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | TPH1, HTR2C, HTR1B | HTR6 14/4885HTR2A 7/4885HTR2C 2/4885 |
| US-11478449-B1 | Compositions of matter and pharmaceutical compositions | TPH1, HTR1B, HTR2C | HTR6 13/4885HTR2A 7/4885HTR2C 3/4885 |
| US-20250064783-A1 | Compositions of Matter and Pharmaceutical Compositions | TPH1, HTR1B, HTR2C | HTR6 13/4885HTR2A 7/4885HTR2C 3/4885 |
| US-12472163-B2 | Compositions of matter and pharmaceutical compositions | TPH1, HTR1B, HTR2C | HTR6 13/4885HTR2A 7/4885HTR2C 3/4885 |
| US-20260115167-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | HTR2C, HTR5A, TPH2 | HTR6 9/4885HTR2A 4/4885HTR2C 1/4885 |
| US-20250041273-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | TPH1, HTR2C, HTR1B | HTR6 14/4885HTR2A 7/4885HTR2C 2/4885 |
| US-20230372295-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | TPH1, HTR2C, HTR1B | HTR6 14/4885HTR2A 7/4885HTR2C 2/4885 |
| US-20220354824-A1 | NOVEL COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | TPH1, HTR2C, HTR1B | HTR6 14/4885HTR2A 7/4885HTR2C 2/4885 |
| US-11759452-B2 | Compositions of matter and pharmaceutical compositions | TPH1, HTR1B, HTR2C | HTR6 13/4885HTR2A 7/4885HTR2C 3/4885 |
| US-20260124174-A1 | COMPOSITIONS OF MATTER AND PHARMACEUTICAL COMPOSITIONS | MAOB, TPH1, TPH2 | HTR6 17/4885HTR2A 14/4885HTR2C 9/4885 |
| US-12053453-B2 | Compositions of matter and pharmaceutical compositions | TPH1, HTR1B, HTR2C | HTR6 13/4885HTR2A 7/4885HTR2C 3/4885 |
| US-12396982-B2 | Compositions of matter and pharmaceutical compositions | TPH1, HTR1B, HTR2C | HTR6 13/4885HTR2A 7/4885HTR2C 3/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.